Literature DB >> 6307865

Control of monocyte C2 production by cyclic AMP.

D Lappin, K Whaley.   

Abstract

We have measured the changes in C2 production and in cyclic nucleotide levels in mononuclear leucocytes cultured in the presence of agents which change intracellular cAMP. Adenylcyclase activators, cholera toxin and phosphodiesterase inhibitors increased cAMP levels and reduced C2 production. Imidazole, hydrocortisone and prostaglandin synthetase inhibitors reduced cAMP and increased C2 synthesis. The level of cAMP after 2 hr incubation showed an inverse correlation with C2 levels in the culture supernatants. When histamine, which increases cAMP and reduces C2 production, and imidazole, which reduces cAMP and increases C2 synthesis, were added together, levels of cAMP and C2 did not differ significantly from those found in control cultures. On the basis of these observations we have concluded that changes in monocyte cAMP alter the production of C2.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6307865      PMCID: PMC1454307     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  12 in total

Review 1.  Biosynthesis of complement components.

Authors:  A R McPhaden; D Lappin; K Whaley
Journal:  J Clin Lab Immunol       Date:  1982-05

2.  Modulation of C2 biosynthesis by antigen-antibody complexes.

Authors:  A R McPhaden; K Whaley
Journal:  J Clin Lab Immunol       Date:  1982-01

3.  Femtomole sensitive radioimmunoassay for cyclic AMP and cyclic GMP after 2'0 acetylation by acetic anhydride in aqueous solution.

Authors:  J F Harper; G Brooker
Journal:  J Cyclic Nucleotide Res       Date:  1975

4.  Mechanism of adenylate cyclase activation by cholera toxin: inhibition of GTP hydrolysis at the regulatory site.

Authors:  D Cassel; Z Selinger
Journal:  Proc Natl Acad Sci U S A       Date:  1977-08       Impact factor: 11.205

5.  Prostaglandins and prostaglandin synthetase inhibitors regulate the synthesis of complement components by human monocytes.

Authors:  D F Lappin; K Whaley
Journal:  Clin Exp Immunol       Date:  1982-09       Impact factor: 4.330

6.  Inhibition of arachidonic acid release from cells as the biochemical action of anti-inflammatory corticosteroids.

Authors:  S L Hong; L Levine
Journal:  Proc Natl Acad Sci U S A       Date:  1976-05       Impact factor: 11.205

7.  Effects of histamine on monocyte complement production. I. Inhibition of C2 production mediated by its action on H2 receptors.

Authors:  D Lappin; K Whaley
Journal:  Clin Exp Immunol       Date:  1980-09       Impact factor: 4.330

8.  Cyclic AMP-mediated modulation of the production of the second component of human complement by monocytes.

Authors:  D Lappin; K Whaley
Journal:  Int Arch Allergy Appl Immunol       Date:  1981

9.  Synthesis of the second component of complement by long-term primary cultures of human monocytes.

Authors:  L P Einstein; E E Schneeberger; H R Colten
Journal:  J Exp Med       Date:  1976-01-01       Impact factor: 14.307

10.  Production of the second component of complement by human monocytes: stimulation by antigen-activated lymphocytes or lymphokines.

Authors:  B H Littman; S Ruddy
Journal:  J Exp Med       Date:  1977-05-01       Impact factor: 14.307

View more
  2 in total

1.  Adenosine A2 receptors on human monocytes modulate C2 production.

Authors:  D Lappin; K Whaley
Journal:  Clin Exp Immunol       Date:  1984-08       Impact factor: 4.330

2.  Vasoactive-intestinal-polypeptide-stimulated adenosine 3',5'-cyclic monophosphate accumulation in GH3 pituitary tumour cells. Reversal of desensitization by forskolin.

Authors:  S Guild; A H Drummond
Journal:  Biochem J       Date:  1984-08-01       Impact factor: 3.857

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.